![](https://investorshub.advfn.com/uicon/656581.png?cb=1524143925)
Sunday, December 23, 2018 5:49:50 PM
• All Australian import authorisations are in place to allow immediate transport to asecure facility at St Vincent’s Hospital, Melbourne
• CannEpilTM is available for supply through Authorised Prescribers, endorsed by theHuman Research Ethics Committee at St Vincent’s Hospital
• CannEpilTM is a Cannabinoids based IMP Phytomedicine developed by MXC
• Some Australian medical practitioners have already been granted approval asAuthorised Prescribers of CannEpilTM
• MXC and specialist pharmaceutical distributor, HL Pharma, are now able to arrangethe supply of CannEpilTM for patients who have been prescribed the product by anAuthorised Prescriber
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM